Abstract
Neural signaling within the central nervous system (CNS) requires a highly controlled microenvironment. Cells at three key interfaces form barriers between the blood and the CNS: the blood–brain barrier (BBB), blood–CSF barrier and the arachnoid barrier. The BBB at the level of brain microvessel endothelium is the major site of blood–CNS exchange. The structure and function of the BBB is summarised, the physical barrier formed by the endothelial tight junctions, and the transport barrier resulting from membrane transporters and vesicular mechanisms. The roles of associated cells are outlined, especially the end feet of astrocytic glial cells, and pericytes and microglia. The embryonic development of the BBB, and changes in pathology are described. The BBB is subject to short and long-term regulation, which may be disturbed in pathology. Any programme for drug discovery or delivery, to target or avoid the CNS, needs to consider the special features of the BBB.
Original language | English |
---|---|
Pages (from-to) | 1-13 |
Journal | Neurobiology of Disease |
Volume | 37 |
Early online date | 5 Aug 2009 |
DOIs | |
Publication status | Published - Jan 2010 |
Externally published | Yes |
Keywords
- Blood-brain barrier
- Blood-CSF-barrier
- Tight junctions
- Permeability
- Transporters
- Receptor-mediated transcytosis
- Adsorptive-mediated transcytosis
- Drug discovery
- Drug delivery
- Development
- Pathology